Androgens and Morphologic Remodeling at Penile and Cardiovascular Levels: A Common Piece in Complicated Puzzles?

European Urology

Volumn 56, Issue 2, 2009, Pages 309-316

  Mirone, Vincenzo ^a   Imbimbo, Ciro ^a   Fusco, Ferdinando ^a   Verze, Paolo ^a   Creta, Massimiliano ^a   Tajana, Gianfranco ^b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY OF SALERNO   (Italy)

Author keywords

Androgens; Endothelial cell; Penile remodeling; Smooth muscle cell; Vascular remodeling

Indexed keywords

ANDROGEN;

APOPTOSIS; CELL DIFFERENTIATION; CELL FUNCTION; CELL HOMING; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; ENDOTHELIUM CELL; HOMEOSTASIS; HUMAN; HYPOGONADISM; MESENCHYMAL STEM CELL; NERVE CELL NETWORK; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

ANDROGENS; CARDIOVASCULAR DISEASES; CARDIOVASCULAR PHYSIOLOGICAL PHENOMENA; HOMEOSTASIS; HUMANS; IMPOTENCE, VASCULOGENIC; MALE; PENIS; SIGNAL TRANSDUCTION;

EID: 67649421397     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2008.12.037     Document Type: Review

References (50)

1. Jones T.H. Testosterone associations with erectile dysfunction, diabetes, and metabolic syndrome. Eur Urol Suppl 6 (2007) 847-857
2. Khaw K.T., Dowsett M., Folkerd E., et al. Endogenous testosterone and mortality due to all causes, cardiovascular disease, and cancer in men: European prospective investigation into cancer in Norfolk (EPIC-Norfolk) Prospective Population Study. Circulation 116 (2007) 2694-2701
3. Traish A.M., and Guay A.T. Are androgens critical for penile erections in humans? Examining the clinical and preclinical evidence. J Sex Med 3 (2006) 382-404
4. Martínez-Jabaloyas J.M., Queipo-Zaragozá A., Rodríguez-Navarro R., Queipo-Zaragozá J.A., Gil-Salom M., and Chuan-Nuez P. Relationship between the Saint Louis University ADAM questionnaire and sexual hormonal levels in a male outpatient population over 50 years of age. Eur Urol 52 (2007) 1760-1767
5. Hatzimouratidis K., and Hatzichristou D. Testosterone and erectile function: an unresolved enigma. Eur Urol 52 (2007) 26-28
6. Osuna J.A., Gómez-Pérez R., Arata-Bellabarba G., and Villaroel V. Relationship between BMI, total testosterone, sex hormone-binding-globulin, leptin, insulin and insulin resistance in obese men. Arch Androl 52 (2006) 355-361
7. Traish A.M., Goldstein I., and Kim N.N. Testosterone and erectile function: from basic research to a new clinical paradigm for managing men with androgen insufficiency and erectile dysfunction. Eur Urol 52 (2007) 54-70
8. Wang D., Xie H., and Wang G. Apoptosis and the expression of Bax and Bcl-2 in the penis of diabetic rats. Zhonghua Nan Ke Xue 10 (2004) 844-848
9. Malkin C.J., Pugh P.J., Jones R.D., Kapoor D., Channer K.S., and Jones T.H. The effect of testosterone replacement on endogenous inflammatory cytokines and lipid profiles in hypogonadal men. J Clin Endocrinol Metab 89 (2004) 3313-3318
10. Rahman F., and Christian H.C. Non-classical actions of testosterone: an update. Trends Endocrinol Metab 18 (2007) 371-378
11. Schober A., and Zernecke A. Chemokines in vascular remodelling. Thromb Haemost 97 (2007) 730-737
12. Li S., Li X., and Li Y. Regulation of atherosclerotic plaque growth and stability by testosterone and its receptor via influence of inflammatory reaction. Vascul Pharmacol 49 (2008) 14-18
13. Cannon J.G. Adaptive interactions between cytokines and the hypothalamic-pituitary-gonadal axis. Ann N Y Acad Sci 856 (1998) 234-242
14. Demirbag R., Yilmaz R., Ulucay A., and Unlu D. The inverse relationship between thoracic aortic intima media thickness and testosterone level. Endocr Res 31 (2005) 335-344
15. Davies J.D., Carpenter K.L., and Challis I.R. Adipocytic differentiation and liver x receptor pathways regulate the accumulation of triacylglycerols in human vascular smooth-muscle cells. J Biol Chem 280 (2005) 3911-3919
16. Lu Y.L., Kuang L., Zhu H., et al. Changes in aortic endothelium ultrastructure in male rats following castration, replacement with testosterone and administration of 5alpha-reductase inhibitor. Asian J Androl 9 (2007) 843-847
17. Foresta C., Zuccarello D., De Toni L., Garolla A., Caretta N., and Ferlin A. Androgens stimulate endothelial progenitor cells through an androgen receptor-mediated pathway. Clin Endocrinol 68 (2008) 284-289
18. Foresta C., Caretta N., Lana A., et al. Relationship between vascular damage degrees and endothelial progenitor cells in patients with erectile dysfunction: effect of vardenafil administration and PDE5 expression in the bone marrow. Eur Urol 51 (2007) 1411-1417
19. Liu D., Iruthayanathan M., Homan L.L., et al. Dehydroepiandrosterone stimulates endothelial proliferation and angiogenesis through extracellular signal-regulated kinase 1/2-mediated mechanisms. Endocrinology 149 (2008) 889-898
20. Liu D., Si H., Reynolds K.A., Zhen W., Jia Z., and Dillon J.S. Dehydroepiandrosterone protects vascular endothelial cells against apoptosis through a Galphai protein-dependent activation of phosphatidylinositol 3-kinase/Akt and regulation of antiapoptotic Bcl-2 expression. Endocrinology 148 (2007) 3068-3076
21. Rauma-Pinola T., Pääkkö P., Ilves M., et al. Adrenomedullin gene transfer induces neointimal apoptosis and inhibits neointimal hyperplasia in injured rat artery. J Gene Med 8 (2006) 452-458
22. Pearson L.J., Rait C., Nicholls M.G., Yandle T.G., and Evans J.J. Regulation of adrenomedullin release from human endothelial cells by sex steroids and angiotensin-II. J Endocrinol 191 (2006) 171-177
23. Garncarczyk A., Jurzak M., and Gojniczek K. Characteristic of the endogenous peptides-endothelins and their role in the connective tissue fibrosis. Wiad Lek 61 (2008) 126-134
24. Kumanov P., Tomova A., and Kirilov G. Testosterone replacement therapy in male hypogonadism is not associated with increase of endothelin-1 levels. Int J Androl 30 (2007) 41-47
25. Norata G.D., Tibolla G., Seccomandi P.M., Poletti A., and Catapano A.L. Dihydrotestosterone decreases tumor necrosis factor-alpha and lipopolysaccharide-induced inflammatory response in human endothelial cells. J Clin Endocrinol Metab 91 (2006) 546-554
26. Hatakeyama H., Nishizawa M., Nakagawa A., Nakano S., Kigoshi T., and Uchida K. Testosterone inhibits tumor necrosis factor-alpha-induced vascular cell adhesion molecule-1 expression in human aortic endothelial cells. FEBS Lett 530 (2002) 129-132
27. Altman R., Motton D.D., Kota R.S., and Rutledge J.C. Inhibition of vascular inflammation by dehydroepiandrosterone sulfate in human aortic endothelial cells: roles of PPARalpha and NF-kappaB. Vascul Pharmacol 48 (2008) 76-84
28. Bowles D.K., Maddali K.K., Dhulipala V.C., and Korzick D.H. PKC delta mediates anti-proliferative, pro-apoptic effects of testosterone on coronary smooth muscle. Am J Physiol Cell Physiol 293 (2007) C805-C813
29. Williams M.R., Ling S., Dawood T., et al. Dehydroepiandrosterone inhibits human vascular smooth-muscle cell proliferation independent of ARs and ERs. J Clin Endocrinol Metab 87 (2002) 176-181
30. Furutama D., Fukui R., Amakawa M., and Ohsawa N. Inhibition of migration and proliferation of vascular smooth-muscle cells by dehydroepiandrosterone sulfate. Biochim Biophys Acta 1406 (1998) 107-114
31. Zhang Y.Z., Xing X.W., He B., and Wang L.X. Effects of testosterone on cytokines and left ventricular remodeling following heart failure. Cell Physiol Biochem 20 (2007) 847-852
32. Nahrendorf M., Frantz S., Hu K., et al. Effect of testosterone on post-myocardial infarction remodeling and function. Cardiovasc Res 57 (2003) 370-378
33. Liu J., Tsang S., and Wong T.M. Testosterone is required for delayed cardioprotection and enhanced heat shock protein 70 expression induced by preconditioning. Endocrinology 147 (2006) 4569-4577
34. Singh R., Artaza J.N., Taylor W.E., Gonzalez-Cadavid N.F., and Bhasin S. Androgens stimulate myogenic differentiation and inhibit adipogenesis in C3H 10T1/2 pluripotent cells through an androgen receptor-mediated pathway. Endocrinology 144 (2003) 5081-5088
35. Singh R., Artaza J.N., Taylor W.E., et al. Testosterone inhibits adipogenic differentiation in 3T3-L1 cells: nuclear translocation of androgen receptor complex with beta-catenin and T-cell factor 4 may bypass canonical Wnt signaling to down-regulate adipogenic transcription factors. Endocrinology 147 (2006) 141-154
36. Iacono F., Giannella R., Somma P., Manno G., Fusco F., and Mirone V. Histological alterations in cavernous tissue after radical prostatectomy. J Urol 173 (2005) 1673-1676
37. Yamamoto H., Sasaki S., and Tatsura H. Penile apoptosis in association with p53 under lack of testosterone. Urol Res 32 (2004) 9-13
38. Zhang X.H., Hu L.Q., Zheng X.M., and Li S.W. Apoptosis in rat erectile tissue induced by castration. Asian J Androl 1 (1999) 181-185
39. Rogers R.S., Graziottin T.M., Lin C.S., Kan Y.W., and Lue T.F. Intracavernosal vascular endothelial growth factor (VEGF) injection and adeno-associated virus-mediated VEGF gene therapy prevent and reverse venogenic erectile dysfunction in rats. Int J Impot Res 15 (2003) 26-37
40. Rajasekaran M., Kasyan A., Allilain W., and Monga M. Ex vivo expression of angiogenic growth factors and their receptors in human penile cavernosal cells. J Androl 24 (2003) 85-90
41. Ryu J.K., Han J.Y., Chu Y.C., et al. Expression of cavernous transforming growth factor-beta1 and its type II receptor in patients with erectile dysfunction. Int J Androl 27 (2004) 42-49
42. Haag S.M., Hauck E.W., Szardening-Kirchner C., et al. Alterations in the transforming growth factor (TGF)-β pathway as a potential factor in the pathogenesis of Peyronie's disease. Eur Urol 51 (2007) 255-261
43. Gelman J., Garbán H., Shen R., et al. Transforming growth factor-beta1 (TGF-beta1) in penile and prostate growth in the rat during sexual maturation. J Androl 19 (1998) 50-57
44. Shabsigh R., Raymond J.F., Olsson C.A., O'Toole K., and Buttyan R. Androgen induction of DNA synthesis in the rat penis. Urology 52 (1998) 723-728
45. Becker A.J., Uckert S., Stief C.G., et al. Cavernous and systemic testosterone plasma levels during different penile conditions in healthy males and patients with erectile dysfunction. Urology 58 (2001) 435-440
46. Shen Z.J., Zhou X.L., Lu Y.L., and Chen Z.D. Effect of androgen deprivation on penile ultrastructure. Asian J Androl 5 (2003) 33-36
47. Armagan A., Hatsushi K., and Toselli P. The effects of testosterone deficiency on the structural integrity of the penile dorsal nerve in the rat. Int J Impot Res 20 (2008) 73-78
48. Baba K., Yajima M., Carrier S., et al. Delayed testosterone replacement restores nitric oxide synthase-containing nerve fibres and the erectile response in rat penis. BJU Int 85 (2000) 953-958
49. Syme D.B., Corcoran N.M., Bouchier-Hayes D.M., Morrison W.A., and Costello A.J. The effect of androgen status on the structural and functional success of cavernous nerve grafting in an experimental rat model. J Urol 177 (2007) 390-394
50. Yassin A.A., and Saad F. Improvement of sexual function in men with late-onset hypogonadism treated with testosterone only. J Sex Med 4 (2007) 497-501